Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Pathology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Future Oncol. 2022 Jul;18(23):2583-2592. doi: 10.2217/fon-2021-1625. Epub 2022 Jun 27.
To explore the appropriate triage methods for women infected with high-risk human papillomavirus (hrHPV). A total of 424 out of 872 hrHPV-infected women were divided into cervicitis (n = 123), cervical intraepithelial neoplasia grade 1 (CIN1; n = 89), CIN2 (n = 72), CIN3 (n = 87) and cervical cancer (n = 53) groups. The sensitivity/specificity of , and liquid-based cytology (LBC) for hrHPV-infected women with transformation zone 3 CIN3+ was 83.9/93.1, 77.4/90.6 and 80.6/58.5%, respectively. The / test had a higher specificity than LBC (p < 0.001) and similar sensitivity to that observed for LBC (p > 0.05). / improved the positive predictive value of CIN3+ (64.7/60.0%) in low-grade LBC (negative predictive value: 91.7/88.7%). was superior to and LBC tests in detecting CIN3+ in hrHPV-infected women.
为了探索针对高危型人乳头瘤病毒(hrHPV)感染女性的合适分诊方法。将 872 例 hrHPV 感染女性中的 424 例分为宫颈炎(n=123)、宫颈上皮内瘤变 1 级(CIN1;n=89)、CIN2(n=72)、CIN3(n=87)和宫颈癌(n=53)组。液基细胞学(LBC)、液基细胞学和细胞学()对于转化区 3 CIN3+的 hrHPV 感染女性的敏感性/特异性分别为 83.9/93.1、77.4/90.6 和 80.6/58.5%。/试验的特异性高于 LBC(p<0.001),与 LBC 的敏感性相似(p>0.05)。/提高了低级别 LBC 中 CIN3+的阳性预测值(64.7/60.0%)(阴性预测值:91.7/88.7%)。/在检测 hrHPV 感染女性的 CIN3+方面优于和 LBC 试验。